Sorrento Provides Updates on CD38 Immunotherapies and Implementation of Disruptive GMP Manufacturing for "Off-The-Shelf" Cell Therapy
Stock Information for Sorrento Therapeutics Inc.
Loading
Please wait while we load your information from QuoteMedia.